{"id":"W4206718482","doi":"10.1007/s40744-021-00415-8","title":"Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials","year":2022,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"UCB Pharma; Sanofi Genzyme; Incyte; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; Canadian Rheumatology Association; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Post-hoc analysis; Rheumatoid arthritis; Post hoc; Medicine; Physical therapy; Internal medicine; Phase (matter); Clinical trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02578241,0.001975939,0.004562324,0.000723152,0.0005976107,0.001634228,0.001173733,0.001329923,0.003806819],"category_scores_gemma":[0.01654172,0.0005743719,0.01040819,0.0009804164,0.0009236729,0.001370784,0.0008668326,0.002343594,0.0004950357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008510428,"about_ca_system_score_gemma":0.001812255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006349059,"about_ca_topic_score_gemma":0.001546717,"domain_scores_codex":[0.9877942,0.008588407,0.001053556,0.001027679,0.0008454809,0.000690654],"domain_scores_gemma":[0.9799296,0.01071783,0.005103062,0.001905549,0.00127248,0.001071538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9499192,0.002155888,0.008184534,0.001006564,0.02426969,0.00006734971,0.00009732946,0.001090107,0.00223003,0.00004099969,0.000788739,0.01014968],"study_design_scores_gemma":[0.5273995,0.2972327,0.1171864,0.0002082427,0.04765853,0.0002848977,0.0001449652,0.003230148,0.003126993,0.0003983573,0.002960631,0.0001685993],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812758,0.008866211,0.001511835,0.0003421301,0.0002474578,0.003001975,0.003163278,0.0001190695,0.001472325],"genre_scores_gemma":[0.9892935,0.00113151,0.001465817,0.0003968227,0.0001885407,0.003898014,0.00277469,0.00004208167,0.0008090679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02578241,"threshold_uncertainty_score":0.136352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02806297952366953,"score_gpt":0.3322063269093806,"score_spread":0.3041433473857111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}